Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...

Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is caused by a single antibody—overturning decades of medical misunderstanding and ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Lower platelet count was identified as a significant predictor for ruxolitinib-induced moderate or ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

A recent case study by the University of Louisville details an incidence where drug-induced thrombocytopenia (DIT) was potentially caused by the use of levofloxacin (of the fluoroquinolone drug class) ...